ArticleBMC medical genomics2019

Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.

J Astor Ankney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.